Pemigatinib
Pemazyre Gains New Indication for Myeloid/Lymphoid Neoplasms
The FDA granted a new indication for Pemazyre to treat adults with relapsed or refractory myeloid/lymphoid ...
AUGUST 30, 2022
Breakthrough Therapy for Advanced Cholangiocarcinoma Approved
The FDA granted accelerated approval to pemigatinib (Pemazyre, Incyte ), the first approved treatment for adults ...
APRIL 21, 2020
Load more